Epirubicin SanoSwiss

Epirubicin SanoSwiss is a cancer medicine that helps slow or stop the growth of cancer cells and increases their chances of dying.

Form
injektioneste, liuos
Strength
2 mg/ml
Active Ingredient
Epirubicin hydrochloride
Manufacturer
SanoSwiss UAB

How to Use

Dosage

Your doctor or nurse will determine your specific dose and treatment schedule based on your type of cancer, health, height, weight, liver function, and other treatments.

Method

The medicine is given as an injection or infusion into a vein (over 3-5 minutes, or a slow drip over 30 minutes if diluted) or directly into the bladder using a tube (catheter). If given into the bladder, do not drink for 12 hours before treatment, and turn your body occasionally to spread the medicine. The solution should stay in the bladder for 1-2 hours.

Important

Your doctor or nurse will carefully determine your dose to ensure it is safe and effective, taking into account your individual health and the overall treatment plan, including any maximum limits.

Possible Side Effects

COMMON
  • Feeling tired, getting infections easily, or bruising easily due to fewer blood cells.
  • Hair loss (usually temporary).
  • Reduced beard growth.
  • Red-colored urine for 1-2 days after treatment.
  • Severe loss of appetite, leading to weight loss.
  • Dehydration (loss of body fluid).
  • Feeling sick to your stomach or throwing up.
  • Diarrhea (can lead to dehydration).
  • Stomach pain.
  • Inflammation of the food pipe (esophagitis).
  • Increased dark spots in the mouth.
  • Swelling, pain, or sores in the mouth, on the lips, or under the tongue.
  • Hot flashes.
  • Fever or infections.
  • Redness, pain, or swelling at the injection site; tissue damage may occur if the medicine accidentally leaks outside the vein.
  • Allergic reactions.
  • Bladder inflammation (sometimes with bleeding) after the medicine is given into the bladder.
RARE
  • Low number of platelets (thrombocytopenia), often causing unusual bruises or bleeding.
  • Headache.
  • Increased dark spots on the skin and nails.
  • Redness of the skin.
  • Skin sensitivity to light (if you also had radiation therapy).
  • Inflammation of a vein, including blood clots (thrombophlebitis).
  • Leukemia (blood cancer).
  • Severe whole-body allergic reaction (anaphylaxis).
  • Hives (urticaria).
  • High levels of uric acid in the blood, which can cause gout.
  • Fever and/or chills.
  • Dizziness.
  • Missed menstrual periods (amenorrhea).
  • Lack of sperm.
  • Gout.
  • Changes in heart or liver function.
  • General feeling of being unwell or weakness.

Important Warnings

  • Do not use if you are allergic to epirubicin hydrochloride or similar cancer medicines (like doxorubicin or daunorubicin), or to any other ingredients in this medicine.
  • Do not use if you are breastfeeding.
  • Do not receive this medicine into a vein if your blood cell counts are low due to previous cancer treatment or radiation therapy.
  • Do not receive this medicine into a vein if you have or have had heart problems.
  • Do not receive this medicine into a vein if you have a severe infection.
Show 2 more warnings
  • Do not receive this medicine into a vein if you have severe liver problems.
  • Do not receive this medicine directly into your bladder if you have a bladder or urinary tract infection, tumors that have spread through the bladder wall, problems inserting a catheter, bladder inflammation, or blood in your urine.